Insulet (PODD) analyst forecast and price target
Analyst forecast
Consensus of 28 analyst ratings
Based on 14 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Truist Securities | Downgraded | Buy → Hold | $153.00 from $210.00 | Aug 6, 2026 |
| JP Morgan | Downgraded | Overweight → Neutral | $152.00 from $275.00 | Aug 6, 2026 |
| Wells Fargo | Downgraded | Overweight → Equal-Weight | $144.00 from $255.00 | Aug 6, 2026 |
| Stifel | Maintained | Buy | $180.00 from $225.00 | Aug 6, 2026 |
| Benchmark | Maintained | Buy | $185.00 from $250.00 | Aug 6, 2026 |
| BTIG | Downgraded | Buy → Neutral | — | Aug 6, 2026 |
| Bernstein | Maintained | Outperform | $175.00 from $200.00 | Aug 6, 2026 |
| RBC Capital | Maintained | Outperform | $160.00 from $245.00 | Aug 6, 2026 |
| UBS | Maintained | Neutral | $150.00 from $174.00 | Aug 6, 2026 |
| TD Cowen | Maintained | Hold | $144.00 from $294.00 | Aug 6, 2026 |
| Leerink Partners | Downgraded | Outperform → Market Perform | $145.00 from $247.00 | Aug 6, 2026 |
| Canaccord Genuity | Maintained | Buy | $179.00 from $249.00 | Aug 6, 2026 |
| UBS | Initiated Coverage | Buy → Neutral | $174.00 | Jul 28, 2026 |
| RBC Capital | Maintained | Outperform | $245.00 from $280.00 | Jul 13, 2026 |
| Truist Securities | Maintained | Buy | $210.00 from $219.00 | Jul 13, 2026 |
| Stifel | Maintained | Buy | $225.00 from $250.00 | Jul 10, 2026 |
| Citigroup | Maintained | Neutral | $172.00 from $165.00 | Jul 8, 2026 |
| Evercore ISI Group | Maintained | Outperform | $180.00 from $200.00 | Jul 6, 2026 |
| Deutsche Bank | Initiated Coverage | Buy | $190.00 | Jun 23, 2026 |
| Truist Securities | Maintained | Buy | $219.00 from $250.00 | Jun 12, 2026 |
Frequently asked questions
What is the price target for PODD stock?
The average 12-month analyst price target for Insulet (PODD) is $164.93, with a high estimate of $190.00 and a low of $144.00, across 14 analysts.
Is PODD a buy, sell, or hold?
Analysts covering Insulet currently average a Buy rating: 16 buy, 12 hold and 0 sell, from 28 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for PODD?
The average price target of $164.93 implies 10.86% upside from the last price of $148.78.
What is the latest analyst rating on PODD?
On Aug 6, 2026, Truist Securities downgraded Insulet to Hold with a price target of $153.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.